Scarica l'app Stockscreener
47.50
0.19%
0.09
Dopo l'orario di chiusura:
47.51
0.010
+0.02%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BMY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Bristol Myers Squibb Co Borsa (BMY) Ultime notizie
Bristol-Myers Squibb: Not As Cheap As It Might Seem (NYSE:BMY) - Seeking Alpha
Gilead starts building manufacturing hub under $32 billion planned US investments - Reuters
Multiple Myeloma Market Size Projected USD 49.89 Billion by 2034 - GlobeNewswire Inc.
Combining machine learning predictions for Bristol Myers Squibb CompanyPortfolio Update Report & Expert Curated Trade Ideas - Newser
Stomach Cancer Treatment Market Review 2020-2024 and Forecast 2025-2030 - GlobeNewswire Inc.
What is Bristol Myers Squibb Company s revenue forecastQuarterly Performance Summary & Reliable Entry Point Trade Alerts - khodrobank.com
Can machine learning forecast Bristol Myers Squibb Company Equity Right recoveryEarnings Recap Report & Technical Confirmation Trade Alerts - Newser
Bristol-Myers Squibb Company (BMY) Launches $300M Immunology Spinout with Bain Capital - MSN
Is it time to cut losses on Bristol Myers Squibb Company Equity RightInsider Buying & Stepwise Trade Signal Guides - Newser
Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
BMS’ WEE1 degrader BMS-986463 as a pan-cancer approach - BioWorld MedTech
Key resistance and support levels for Bristol Myers Squibb Company2025 Key Lessons & Step-by-Step Trade Execution Guides - Newser
Visual trend scoring systems applied to Bristol Myers Squibb Company Equity RightM&A Rumor & Low Risk Entry Point Tips - Newser
Risk vs reward if holding onto Bristol Myers Squibb Company Equity RightEarnings Growth Report & Growth Focused Stock Pick Reports - Newser
Long term hold vs stop loss in Bristol Myers Squibb Company Equity Right2025 Support & Resistance & Growth Focused Stock Pick Reports - Newser
Bristol Myers Squibb Company Equity Right’s volatility index tracking explained2025 Market Outlook & Risk Managed Investment Signals - Newser
BMO Capital Maintains a Hold on Bristol-Myers Squibb (BMY) - Yahoo Finance
How to interpret RSI for Bristol Myers Squibb Company stockEarnings Risk Report & Fast Gain Stock Tips - Newser
Using data tools to time your Bristol Myers Squibb Company Equity Right exit2025 Key Lessons & Reliable Breakout Forecasts - Newser
Investors three-year losses continue as Bristol-Myers Squibb (NYSE:BMY) dips a further 3.2% this week, earnings continue to decline - Yahoo Finance
Layoff Tracker: Exelixis Cuts Go Beyond Pennsylvania, Include 71 at California HQ - BioSpace
Price action breakdown for Bristol Myers Squibb CompanyJuly 2025 Earnings & Safe Swing Trade Setups - Newser
Can momentum traders help lift Bristol Myers Squibb CompanyWeekly Market Outlook & Momentum Based Trading Ideas - Newser
What MACD signals say about Bristol Myers Squibb Company Equity RightMarket Sentiment Review & Fast Gain Stock Trading Tips - Newser
News impact scoring models applied to Bristol Myers Squibb CompanyEarnings Risk Summary & Daily Technical Forecast Reports - Newser
Real time social sentiment graph for Bristol Myers Squibb CompanyWeekly Risk Summary & AI Optimized Trading Strategy Guides - Newser
How to track smart money flows in Bristol Myers Squibb Company Equity RightJuly 2025 Update & AI Driven Price Predictions - Newser
Chart based exit strategy for Bristol Myers Squibb CompanyJuly 2025 Recap & Capital Protection Trade Alerts - Newser
Chart based analysis of Bristol Myers Squibb Company Equity Right trendsWeekly Investment Summary & Growth Oriented Trade Recommendations - Newser
Should you wait for a breakout in Bristol Myers Squibb CompanyJuly 2025 Opening Moves & Capital Protection Trade Alerts - Newser
Can Bristol Myers Squibb Company lead its sector in growth getLinesFromResByArray error: size == 0 - mustnews.co.kr
Discovery of dual molecular glue degrader BMS-986470 - BioWorld MedTech
What momentum shifts mean for Bristol Myers Squibb CompanyWeekly Market Outlook & Free Weekly Watchlist of Top Performers - Newser
Can Bristol Myers Squibb Company hit a new high this month2025 Buyback Activity & Expert Verified Stock Movement Alerts - Newser
Cantor Fitzgerald Cuts Bristol-Myers (BMY) Price Target, Keeps Neutral - Insider Monkey
Will Camzyos Strengthen BMY's Cardiovascular Portfolio? - Yahoo Finance
What data driven models say about Bristol Myers Squibb Company Equity Right’s futureJuly 2025 Highlights & Fast Moving Market Watchlists - Newser
Branded Pharmaceuticals Stocks Q2 Recap: Benchmarking Bristol-Myers Squibb (NYSE:BMY) - Yahoo Finance
Order flow analysis tools used on Bristol Myers Squibb Company Equity RightMarket Movement Recap & Step-by-Step Trade Execution Guides - Newser
Signal strength of Bristol Myers Squibb Company stock in tech scannersJuly 2025 Highlights & Free Risk Controlled Daily Trade Plans - Newser
Analyzing Bristol Myers Squibb Company with multi timeframe chartsPortfolio Performance Report & Daily Volume Surge Trade Alerts - Newser
Is Bristol Myers Squibb Company stock bottoming outWeekly Trend Report & AI Powered Market Entry Ideas - Newser
Earnings visualization tools for Bristol Myers Squibb CompanyWeekly Profit Analysis & Free Expert Approved Momentum Trade Ideas - Newser
Published on: 2025-08-26 17:49:14 - beatles.ru
Using Ichimoku Cloud for Bristol Myers Squibb Company Equity Right technicalsJuly 2025 Summary & Low Drawdown Trading Strategies - Newser
Bristol Myers Squibb Co. stock underperforms Monday when compared to competitors - MarketWatch
Should You Revisit Bristol-Myers Squibb Amid Uncertainty Over Pharma Tariffs in 2025? - Yahoo Finance
Business development leadership team - Bristol Myers Squibb
Is Bristol Myers Squibb Company impacted by rising rates2025 Price Action Summary & Daily Stock Trend Watchlist - theviewers.co.kr
Bristol-Myers Squibb Company (NYSE:BMY) is favoured by institutional owners who hold 82% of the company - Yahoo Finance
BMY vs GSK: Which Biopharma Bigwig Has Better Prospects for Now? - Yahoo Finance
Career oncologist makes Big Pharma leap to BMS—Chutes & Ladders - fiercebiotech.com
ServiceNow, Live Nation Entertainment And A Health Care Stock: CNBC's 'Final Trades' - Benzinga
Lilly neuro exec Anne White to retire; Bristol Myers fills new medical affairs position - Endpoints News
The Escalator: Bristol Myers Squibb, Eli Lilly, Stephen Hahn and more - Medical Marketing and Media
0.63%
0.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):